They retrospectively analyzed pretreatment breast DCE-MRI of 60 breast cancer patients, where 34 were diagnosed with luminal A breast cancers, 8 with luminal B, 7 with HER2, and 11 with basal-like. Here, ERBB2 is linked to breast cancer.